Genome sequence of a proteolytic (Group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes
- PMID: 17519437
- PMCID: PMC1899119
- DOI: 10.1101/gr.6282807
Genome sequence of a proteolytic (Group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes
Abstract
Clostridium botulinum is a heterogeneous Gram-positive species that comprises four genetically and physiologically distinct groups of bacteria that share the ability to produce botulinum neurotoxin, the most poisonous toxin known to man, and the causative agent of botulism, a severe disease of humans and animals. We report here the complete genome sequence of a representative of Group I (proteolytic) C. botulinum (strain Hall A, ATCC 3502). The genome consists of a chromosome (3,886,916 bp) and a plasmid (16,344 bp), which carry 3650 and 19 predicted genes, respectively. Consistent with the proteolytic phenotype of this strain, the genome harbors a large number of genes encoding secreted proteases and enzymes involved in uptake and metabolism of amino acids. The genome also reveals a hitherto unknown ability of C. botulinum to degrade chitin. There is a significant lack of recently acquired DNA, indicating a stable genomic content, in strong contrast to the fluid genome of Clostridium difficile, which can form longer-term relationships with its host. Overall, the genome indicates that C. botulinum is adapted to a saprophytic lifestyle both in soil and aquatic environments. This pathogen relies on its toxin to rapidly kill a wide range of prey species, and to gain access to nutrient sources, it releases a large number of extracellular enzymes to soften and destroy rotting or decayed tissues.
Figures
Similar articles
-
Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum.BMC Genomics. 2009 Mar 19;10:115. doi: 10.1186/1471-2164-10-115. BMC Genomics. 2009. PMID: 19298644 Free PMC article.
-
Complete genome sequence of the proteolytic Clostridium botulinum type A5 (B3') strain H04402 065.J Bacteriol. 2011 May;193(9):2351-2. doi: 10.1128/JB.00072-11. Epub 2011 Mar 4. J Bacteriol. 2011. PMID: 21378191 Free PMC article.
-
Genomes, neurotoxins and biology of Clostridium botulinum Group I and Group II.Res Microbiol. 2015 May;166(4):303-17. doi: 10.1016/j.resmic.2014.10.010. Epub 2014 Nov 4. Res Microbiol. 2015. PMID: 25445012 Free PMC article. Review.
-
Pan-Genomic Analysis of Clostridium botulinum Group II (Non-Proteolytic C. botulinum) Associated with Foodborne Botulism and Isolated from the Environment.Toxins (Basel). 2020 May 8;12(5):306. doi: 10.3390/toxins12050306. Toxins (Basel). 2020. PMID: 32397147 Free PMC article.
-
Biology and genomic analysis of Clostridium botulinum.Adv Microb Physiol. 2009;55:183-265, 320. doi: 10.1016/S0065-2911(09)05503-9. Adv Microb Physiol. 2009. PMID: 19573697 Review.
Cited by
-
Exploring genomic diversity in Clostridium botulinum using DNA microarrays.Botulinum J. 2012;2(2):99-108. doi: 10.1504/tbj.2012.050195. Botulinum J. 2012. PMID: 39130517 Free PMC article.
-
Hacking the Immune Response to Solid Tumors: Harnessing the Anti-Cancer Capacities of Oncolytic Bacteria.Pharmaceutics. 2023 Jul 21;15(7):2004. doi: 10.3390/pharmaceutics15072004. Pharmaceutics. 2023. PMID: 37514190 Free PMC article. Review.
-
Pathogenicity and virulence of Clostridium botulinum.Virulence. 2023 Dec;14(1):2205251. doi: 10.1080/21505594.2023.2205251. Virulence. 2023. PMID: 37157163 Free PMC article. Review.
-
Physical Treatments to Control Clostridium botulinum Hazards in Food.Foods. 2023 Apr 7;12(8):1580. doi: 10.3390/foods12081580. Foods. 2023. PMID: 37107375 Free PMC article. Review.
-
Genomic Diversity, Competition, and Toxin Production by Group I and II Clostridium botulinum Strains Used in Food Challenge Studies.Microorganisms. 2022 Sep 23;10(10):1895. doi: 10.3390/microorganisms10101895. Microorganisms. 2022. PMID: 36296172 Free PMC article.
References
-
- Anonymous. Wound botulism in injecting drug users in the United Kingdom. CDR Weekly. 2006 http://www.camr.org.uk/cdr/archives/archive06/News/news1306.htm#bot.
-
- Arnold F., Bedouet L., Batina P., Robreau G., Talbot F., Lecher P., Malcoste R., Bedouet L., Batina P., Robreau G., Talbot F., Lecher P., Malcoste R., Batina P., Robreau G., Talbot F., Lecher P., Malcoste R., Robreau G., Talbot F., Lecher P., Malcoste R., Talbot F., Lecher P., Malcoste R., Lecher P., Malcoste R., Malcoste R. Biochemical and immunological analyses of the flagellin of Clostridium tyrobutyricum ATCC 25755. Microbiol. Immunol. 1998;42:23–31. - PubMed
-
- Arnon S.S. Infant botulism. In: Feigen R.D., Cherry J.D., Cherry J.D., editors. Textbook of pediatric infectious disease. Saunders; Philadelphia: 2004. pp. 1758–1766.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases